November 10, 2026 Experience Pacific Biosciences $100 million at-the-market offering We advised the sales agent on the offering
November 10, 2026 Experience Ventas $500 million senior notes offering We advised Ventas on its investment-grade debt offering
November 5, 2026 Experience bit.bio $25 million series D equity financing We are advising the company on the funding round
October 28, 2026 Experience Olympus $500 million senior notes offering We advised Olympus on the offering
October 23, 2026 Experience ADC Therapeutics $86 million private placement We advised ADC Therapeutics on the transaction involving its common shares and pre-funded warrants
October 22, 2026 Experience Kodiak Sciences $350 million at-the-market offering We advised the sales agent on the offering
October 22, 2026 Experience QIAGEN $12.1 billion takeover offer by EQT Private Equity We are advising QIAGEN on the transaction
October 19, 2026 Experience Alector $75 million registered direct offering We advised the underwriters on the offering
October 19, 2026 Experience TCGX Acquisition Corp. II $100 million SPAC IPO We advised the sole bookrunning manager on the IPO
October 16, 2026 Experience Recursion Pharmaceuticals $200 million follow-on offering We advised the underwriters on the offering